BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29940877)

  • 1. Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Orlandi PF; Fujii N; Roy J; Chen HY; Lee Hamm L; Sondheimer JH; He J; Fischer MJ; Rincon-Choles H; Krishnan G; Townsend R; Shafi T; Hsu CY; Kusek JW; Daugirdas JT; Feldman HI;
    BMC Nephrol; 2018 Jun; 19(1):150. PubMed ID: 29940877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrupt Decline in Kidney Function Before Initiating Hemodialysis and All-Cause Mortality: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Hsu RK; Chai B; Roy JA; Anderson AH; Bansal N; Feldman HI; Go AS; He J; Horwitz EJ; Kusek JW; Lash JP; Ojo A; Sondheimer JH; Townsend RR; Zhan M; Hsu CY;
    Am J Kidney Dis; 2016 Aug; 68(2):193-202. PubMed ID: 26830447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ricardo AC; Anderson CA; Yang W; Zhang X; Fischer MJ; Dember LM; Fink JC; Frydrych A; Jensvold NG; Lustigova E; Nessel LC; Porter AC; Rahman M; Wright Nunes JA; Daviglus ML; Lash JP;
    Am J Kidney Dis; 2015 Mar; 65(3):412-24. PubMed ID: 25458663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression.
    Ying T; Clayton P; Naresh C; Chadban S
    BMC Nephrol; 2018 Mar; 19(1):55. PubMed ID: 29514605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Impairment and Progression of CKD.
    Kurella Tamura M; Yaffe K; Hsu CY; Yang J; Sozio S; Fischer M; Chen J; Ojo A; DeLuca J; Xie D; Vittinghoff E; Go AS;
    Am J Kidney Dis; 2016 Jul; 68(1):77-83. PubMed ID: 26972681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary patterns and risk of death and progression to ESRD in individuals with CKD: a cohort study.
    Gutiérrez OM; Muntner P; Rizk DV; McClellan WM; Warnock DG; Newby PK; Judd SE
    Am J Kidney Dis; 2014 Aug; 64(2):204-13. PubMed ID: 24679894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality.
    Ku E; Kopple JD; Johansen KL; McCulloch CE; Go AS; Xie D; Lin F; Hamm LL; He J; Kusek JW; Navaneethan SD; Ricardo AC; Rincon-Choles H; Smogorzewski M; Hsu CY;
    Am J Kidney Dis; 2018 May; 71(5):657-665. PubMed ID: 29217305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.
    Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH; Jummaat F
    Nephrology (Carlton); 2017 Jan; 22(1):25-34. PubMed ID: 26718476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.
    Waikar SS; Srivastava A; Palsson R; Shafi T; Hsu CY; Sharma K; Lash JP; Chen J; He J; Lieske J; Xie D; Zhang X; Feldman HI; Curhan GC;
    JAMA Intern Med; 2019 Apr; 179(4):542-551. PubMed ID: 30830167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-Related Disparities in CKD Progression.
    Ricardo AC; Yang W; Sha D; Appel LJ; Chen J; Krousel-Wood M; Manoharan A; Steigerwalt S; Wright J; Rahman M; Rosas SE; Saunders M; Sharma K; Daviglus ML; Lash JP;
    J Am Soc Nephrol; 2019 Jan; 30(1):137-146. PubMed ID: 30510134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Anderson AH; Xie D; Wang X; Baudier RL; Orlandi P; Appel LJ; Dember LM; He J; Kusek JW; Lash JP; Navaneethan SD; Ojo A; Rahman M; Roy J; Scialla JJ; Sondheimer JH; Steigerwalt SP; Wilson FP; Wolf M; Feldman HI;
    Am J Kidney Dis; 2021 Jan; 77(1):56-73.e1. PubMed ID: 32866540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
    Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
    Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
    Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study.
    Bansal N; Roy J; Chen HY; Deo R; Dobre M; Fischer MJ; Foster E; Go AS; He J; Keane MG; Kusek JW; Mohler E; Navaneethan SD; Rahman M; Hsu CY;
    Am J Kidney Dis; 2018 Sep; 72(3):390-399. PubMed ID: 29784617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the Urine-to-Plasma Urea Ratio With CKD Progression.
    Liu J; Bankir L; Verma A; Waikar SS; Palsson R
    Am J Kidney Dis; 2023 Apr; 81(4):394-405. PubMed ID: 36356680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease.
    Holm Nielsen S; Guldager Kring Rasmussen D; Brix S; Fenton A; Jesky M; Ferro CJ; Karsdal M; Genovese F; Cockwell P
    PLoS One; 2018; 13(10):e0204239. PubMed ID: 30273365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.